Visual Field Outcomes in Optic Pathway Glioma After Bevacizumab Therapy

Update Item Information
Identifier 20220213_nanos_posters_342
Title Visual Field Outcomes in Optic Pathway Glioma After Bevacizumab Therapy
Creator Daniel Nelson; Benjamin Siegel; Tobey MacDonald; David Wolf; Jason Peragallo
Affiliation (DN) (JP) Emory University School of Medicine, Department of Ophthalmology, Atlanta, GA; (BS) Emory School of Medicine, Department of Neurology, Atlanta, GA; (TM) (DW) Emory University School of Medicine, Department of Pediatrics, Atlanta, GA
Subject Pediatric Neuro-ophthalmology; Visual fields; Tumors
Description Systemic bevacizumab is a promising therapy for optic pathway glioma (OPG) radiographic tumor burden1, but little is known about its impact on visual function2,3. Our objective is to characterize visual field outcomes associated with bevacizumab-based therapy (BBT) for OPG.
Date 2022-02
Language eng
Format application/pdf
Type Text
Source 2022 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2022: Poster Session I: Pediatric Neuro-Ophthalmology
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6dkdx96
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Setname ehsl_novel_nam
ID 2065361
Reference URL https://collections.lib.utah.edu/ark:/87278/s6dkdx96
Back to Search Results